Advanced Fallopian Tube Carcinoma

Drug	Drug Name	Drug Description
DB09074	Olaparib	A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Drug	Drug Name	Target	Type
DB09074	Olaparib	Poly [ADP-ribose] polymerase 1	target
DB09074	Olaparib	Cytochrome P450 3A4	enzyme
DB09074	Olaparib	Cytochrome P450 2B6	enzyme
DB09074	Olaparib	Poly [ADP-ribose] polymerase 2	target
DB09074	Olaparib	Poly [ADP-ribose] polymerase 3	target
DB09074	Olaparib	Cytochrome P450 3A5	enzyme
DB09074	Olaparib	P-glycoprotein 1	transporter
DB09074	Olaparib	ATP-binding cassette sub-family G member 2	transporter
DB09074	Olaparib	Aldo-keto reductase family 1 member C3	target
DB09074	Olaparib	UDP-glucuronosyltransferase 1-1	enzyme
DB09074	Olaparib	Serum albumin	carrier
DB09074	Olaparib	Alpha-1-acid glycoprotein 1	carrier

Drug	Drug Name	Phase	Status	Count
DB11740	Adavosertib	0	Active Not Recruiting	1
DB18028	Azenosertib	0	Withdrawn	1
DB00062	Albumin human	1	Recruiting	1
DB11595	Atezolizumab	1	Recruiting	1
DB08875	Cabozantinib	1	Recruiting	1
DB00441	Gemcitabine	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Active Not Recruiting	1
DB01262	Decitabine	1 / 2	Active Not Recruiting	1
DB17107	Lifileucel	1 / 2	Active Not Recruiting	1